Scream 7: 1% to Be Top-Grossing 2026 — Live Odds

Scream 7 is the latest installment in the iconic slasher franchise, continuing over two decades of horror cinema. At 1% market-implied odds, traders are confident it will not finish 2026 as the year's highest-grossing film. This reflects both the franchise's recent box office trajectory and the broader competitive landscape for major releases in 2026. The 2022 Scream reboot earned approximately $140 million globally—respectable for a horror film but far short of blockbuster tentpoles. In 2026, Scream 7 will compete against major studio releases spanning superhero franchises, animated sequels, sci-fi epics, and other event films with substantially larger marketing budgets and audience reach. Horror films, while culturally significant and profitable, rarely dominate annual box office charts against mainstream blockbusters. The 1% odds imply traders expect top-grossing candidates to emerge from established franchises or major studio tentpoles with broader appeal. Scream 7 would need exceptional critical reception, word-of-mouth momentum, and minimal competition from other major releases to defy these expectations.

What factors could move this market?

The Scream franchise, launched in 1996 by Wes Craven, became a cultural phenomenon that both honored and subverted horror conventions. The original film grossed $103 million worldwide on a $14 million budget, spawning direct sequels and establishing a template for meta-horror cinema. However, franchise performance has been uneven in recent decades. Scream (2022), marketed as a 'requel' to revitalize the series, earned $140 million globally—lower than many anticipated for a legacy franchise with dedicated fan interest. This performance, while profitable, sits well below the top-grossing films of their respective years, suggesting ceiling effects for the franchise in the modern blockbuster era. What would drive Scream 7 toward the top-grossing position? The film would need unprecedented critical acclaim establishing it as a prestige horror event, sustained cultural conversation generating massive word-of-mouth, and exceptional box office legs in multiple territories. It would also require minimal direct competition from major franchises during its release window—a scenario increasingly rare in the crowded theatrical calendar. Conversely, factors supporting the 1% odds are substantial. In 2026, major studios are expected to release superhero sequels, big-budget sci-fi films, animated franchises, and tentpoles with global appeal and $150+ million marketing budgets. A single Marvel or Star Wars release typically outgrosses successful horror films by 3-5 times. The horror genre, while consistently profitable, historically underperforms action and franchise blockbusters in absolute box office terms. Box office data from 2024-2025 shows no horror film in the top ten highest-grossing films globally; top-grossing horror films typically rank between 20-50 depending on the year. Scream 7 would need to transcend category performance norms to claim the top spot. The current 1% odds reflect this reality: traders are treating it as a true tail event. The market liquidity of $139K and modest 24h volume of $7.8K suggest limited retail interest, a sign that even speculators see the outcome as highly improbable.

What are traders watching for?

• Scream 7 release date and opening weekend box office numbers; strong debut essential for any top-grossing trajectory.
• Major tentpole releases throughout 2026 (superhero franchises, sci-fi epics, animated sequels) will likely outpace a horror entry.
• Critical reception and audience word-of-mouth drive long-term legs; prestige status could unlock unexpected box office longevity.
• Weekly box office tracking from launch through Dec 31, 2026; final worldwide total determines resolution.

How does this market resolve?

Market resolves YES if Scream 7 achieves the highest worldwide box office total among all films released or widely distributed in 2026 by Dec 31, 2026; otherwise NO.